Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announces that CEO John F. Crowley will participate in a fireside chat at the Goldman Sachs 41^st Annual Global Healthcare Conference on June 10, 2020, at 8:00 a.m. ET. This event will take place virtually, allowing interested parties to access a live audio webcast via the company's Investor Relations page. Amicus Therapeutics focuses on developing innovative medicines for rare metabolic diseases, furthering its commitment to patients through a robust pipeline of advanced therapies. For details, visit www.amicusrx.com.

CRANBURY, N.J., June 04, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 41^st Annual Global Healthcare Conference, being held virtually on Wednesday, June 10, 2020 at 8:00 a.m. ET.

A live audio webcast of the presentation can also be accessed via the Investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.

CONTACTS:

Investors/Media:
Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

FOLD–G

FAQ

When is Amicus Therapeutics participating in the Goldman Sachs conference?

Amicus Therapeutics will participate in the Goldman Sachs 41st Annual Global Healthcare Conference on June 10, 2020, at 8:00 a.m. ET.

Who will represent Amicus Therapeutics at the Goldman Sachs conference?

John F. Crowley, the Chairman and CEO of Amicus Therapeutics, will represent the company at the conference.

How can I access the webcast of the Amicus Therapeutics presentation?

The live audio webcast can be accessed via the Investors section of the Amicus Therapeutics corporate website.

What is the focus of Amicus Therapeutics?

Amicus Therapeutics is focused on discovering and developing novel medicines for rare metabolic diseases.

What stock symbol represents Amicus Therapeutics?

Amicus Therapeutics is traded under the stock symbol 'FOLD' on Nasdaq.